AIM Vaccine Enters the Period of Explosive Growth in Major Single Products
- Written by The Bulletin
Leading the Two Golden Tracks of Pneumonia Vaccine and Rabies Vaccines
HONG KONG SAR - Media OutReach Newswire - 4 March 2024 - AIM Vaccine Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that the company has made significant progress in the research and development of its Pneumonia vaccine and Rabies vaccine products.Read more: AIM Vaccine Enters the Period of Explosive Growth in Major Single Products
